Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ASRT Assertio Holdings Inc
- Stocks
- Healthcare
- NASDAQ: ASRT
Price (delayed)
$0.6119
Market cap
$58.61M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.32
Enterprise value
$62.53M
Highlights
The company's EPS has surged by 91% YoY but it fell by 39% QoQ
ASRT's net income has surged by 91% year-on-year but it is down by 42% since the previous quarter
The gross profit has decreased by 24% YoY and by 3% QoQ
ASRT's equity is down by 19% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of ASRT
Market
Valuations
Earnings
Shares outstanding
95.78M
Market cap
$58.61M
Enterprise value
$62.53M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.54
Price to sales (P/S)
0.49
EV/EBIT
N/A
EV/EBITDA
31.24
EV/Sales
0.53
Revenue
$119M
Gross profit
$83.17M
Operating income
-$33.62M
Net income
-$30.61M
EBIT
-$27.4M
EBITDA
$2M
Free cash flow
$6.36M
Per share
Balance sheet
Liquidity
EPS
-$0.32
EPS diluted
-$0.32
Free cash flow per share
$0.07
Book value per share
$1.13
Revenue per share
$1.24
TBVPS
$2.25
Total assets
$286.43M
Total liabilities
$177.9M
Debt
$38.93M
Equity
$108.53M
Working capital
$84.72M
Debt to equity
0.36
Current ratio
1.66
Quick ratio
1.19
Net debt/EBITDA
1.96
Margins
Efficiency
Dividend
EBITDA margin
1.7%
Gross margin
69.9%
Net margin
-25.7%
Operating margin
-28.2%
Return on assets
-10.9%
Return on equity
-24.9%
Return on invested capital
-31.8%
Return on capital employed
-17.4%
Return on sales
-23%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ASRT stock price
How has the Assertio Holdings stock price performed over time
Intraday
0.53%
1 week
-0.84%
1 month
-1.59%
1 year
-39.42%
YTD
-29.76%
QTD
-9.29%
Financial performance
How have Assertio Holdings's revenue and profit performed over time
Revenue
$119M
Gross profit
$83.17M
Operating income
-$33.62M
Net income
-$30.61M
Gross margin
69.9%
Net margin
-25.7%
ASRT's net income has surged by 91% year-on-year but it is down by 42% since the previous quarter
ASRT's net margin has surged by 89% year-on-year but it is down by 49% since the previous quarter
Assertio Holdings's operating income has surged by 88% YoY but it has decreased by 36% QoQ
ASRT's operating margin has soared by 86% YoY but it is down by 42% QoQ
Price vs fundamentals
How does ASRT's price correlate with its fundamentals
Growth
What is Assertio Holdings's growth rate over time
Valuation
What is Assertio Holdings stock price valuation
P/E
N/A
P/B
0.54
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
31.24
EV/Sales
0.53
The company's EPS has surged by 91% YoY but it fell by 39% QoQ
The stock's P/B is 40% less than its 5-year quarterly average of 0.9 and 33% less than its last 4 quarters average of 0.8
ASRT's equity is down by 19% year-on-year and by 10% since the previous quarter
ASRT's price to sales (P/S) is 46% lower than its 5-year quarterly average of 0.9 and 30% lower than its last 4 quarters average of 0.7
The revenue has declined by 16% year-on-year and by 4.8% since the previous quarter
Efficiency
How efficient is Assertio Holdings business performance
The company's return on invested capital has surged by 93% YoY but it fell by 27% QoQ
The ROA has soared by 89% year-on-year but it is down by 42% since the previous quarter
The company's return on sales has surged by 87% YoY but it has shrunk by 55% QoQ
The ROE has soared by 87% YoY but it has contracted by 49% from the previous quarter
Dividends
What is ASRT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ASRT.
Financial health
How did Assertio Holdings financials performed over time
The total assets is 61% more than the total liabilities
ASRT's total liabilities is up by 21% YoY and by 9% QoQ
Assertio Holdings's quick ratio has decreased by 11% QoQ and by 11% YoY
ASRT's debt is 64% smaller than its equity
The debt to equity has increased by 24% YoY and by 13% from the previous quarter
ASRT's equity is down by 19% year-on-year and by 10% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.